Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by education grants from: Bristol Myers Squibb, Incyte Corporation, Protagonist Therapeutics, and Sumitomo Dainippon Pharma Oncology.

Advances in MF and PV: Individualizing Care Based on Patient- and Disease-Specific Factors

Release Date: August 31, 2021
Expiration Date: August 31, 2022


Activity Overview

Myeloproliferative neoplasms (MPNs) comprise a diverse range of hematologic cancers, with optimal management requiring careful risk stratification and treatment planning. In recent years, refinements in disease biology and development of novel therapeutic options have led to improved control of symptoms and lessened risk of serious adverse events.

This virtual, on-demand webcast is specifically designed to meet the needs of busy clinicians who treat patients who have received a diagnosis of polycythemia vera (PV) or myelofibrosis (MF) by providing an update on optimal risk stratification, treatment selection, and emerging therapeutic options. These didactic presentations are placed into real-world context through discussion of 4 case scenarios spanning the disease continuum for PV and MF. These cases will help place recent findings and treatment recommendations into context for participants.
 

Acknowledgement of Commercial Support

This activity is supported by education grants from: Bristol Myers Squibb, Incyte Corporation, Protagonist Therapeutics, and Sumitomo Dainippon Pharma Oncology.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational activity is directed toward hematologists, medical oncologists, nurse practitioners, nurses, and fellows who treat patients given a diagnosis of a MPN. Physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of MPNs will be invited to participate.
 

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Develop an individualized care plan based on genetics, risk stratification, and symptom burden for patients with MF or PV.
  • Evaluate safety and efficacy data concerning novel and emerging treatment options for managing MF or PV.
  • Outline strategies to identify and manage disease-associated symptoms and treatment-related toxicities in patients given a diagnosis of MF or PV.  
  • Integrate emerging data into clinical scenarios, with a focus on optimizing care across the MPN disease continuum.

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

Chair

Gregory J. Riely, MD, PhD
Srdan Verstovsek, MD, PhD
United Energy Resources, Inc, Professor of Medicine
Director, Hanns A. Pielenz Clinical Research Center
for Myeloproliferative Neoplasms
Chief, Section for Proliferative Neoplasms
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Disclosures: Grant research support: Incyte, Roche, NS Pharma, Celgene, Gilead Sciences, Promedior, CTI BioPharma, AbbVie, Blueprint Medicines, Novartis Pharmaceuticals, Sierra Oncology, PharmaEssentia, Constellation Pharmaceuticals, Italfarmaco SpA, Protagonist Therapeutics, Kartos Therapeutics.


Faculty

Ramaswamy Govindan, MD
Andrew Kuykendall, MD
Assistant Member
Department of Malignant Hematology
H. Lee Moffitt Cancer Center
Tampa, FL

 

Disclosures: Grant Research Support: Protagonist Therapeutics, Sierra Oncology, Prelude Therapeutics, Celgene/Bristol Myers Squibb, Incyte; Consultant: Protagonist Therapeutics, AbbVie, Novartis Pharmaceuticals, PharmaEssentia, Incyte; Speaker’s Bureau: Blueprint Medicines, Novartis Pharmaceuticals.
 

Vamsidhar Velcheti, MD
Raajit K. Rampal, MD, PhD
Associate Member
Clinical Director, Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, NY

 

Disclosures: Grant Research Support: Incyte, Stemline Therapeutics, Constellation Pharmaceuticals; Consultant: Incyte, Celgene/Bristol Myers Squibb, Disc Medicine, Sierra Oncology, Novartis Pharmaceuticals, Blueprint Medicines, PharmaEssentia, CTI BioPharma, Stemline Therapeutics, AbbVie, Constellation Pharmaceuticals, Kartos Therapeutics, Jazz Pharmaceuticals.
 

Vamsidhar Velcheti, MD
Abdulraheem Yacoub, MD
Associate Professor of Medicine
Clinical Director, Ambulatory Hematology Clinics
Division of Hematologic Malignancies and Cellular Therapeutics
The University of Kansas Cancer Center
University of Kansas Medical Center
Kansas City, KS
 

Disclosures: Consultant: Novartis Pharmaceuticals, CTI BioPharma, Acceleron Pharma, Agios Pharmaceuticals; Speaker’s Bureau: Incyte, Agios Pharmaceuticals, Novartis Pharmaceuticals.

 

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
   1234
567891011
12131415161718
19202122232425
2627282930
Filter By